“…The U.S. Food and Drug Administration (FDA) has approved PHAs for several biomedical applications [ 28 , 31 ]. Hence, the polymer has been widely investigated for artificial cartilages, dressing of wounds, artificial vessels, tendon healing, tubular substitutes, heart valves, bone grafts and stents for nerve repair [ 28 , 29 , 30 , 31 , 32 , 33 , 34 ], as summarized in Table 1 . In fact, up to date, the US FDA has approved a number of PHA-based products, including TephaFLEX ® (sutures made of poly (4-hydroxybutyrate), P(4HB)) [ 31 , 35 ], Phasix TM (mesh made from P(4HB) for the treatment of hernia) [ 31 , 36 ] and Monomax ® (sutures made of P(4HB)) [ 31 , 37 ].…”